*****ON THE WATCHLIST FOR NEXT WEEK AS STOCK HAS BEEN ACTING QUITE BULLISH IN RECENT DAYS*****
CAMBRIDGE, Mass., May 29, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (INFI) announced today that members of the management team will be participating in the 2019 BIO International Convention at Pennsylvania Convention Center, Philadelphia, PA.
Adelene Perkins,...
INFI
Key levels: 0.92, 1.95
Because of the risk seen in this chart (rangy, poor movement, no pattern, bearish overall trend, selling off after gains and not holding support) we will remain skeptical on the potential until we see healthier movement.
Healthier movement on this one will look like 0.92 holding up as a support to create a triple bottom on the...
If you read my prior post, I tipped you off about the opportunity to get in here around 2.28-2.32. Now it's ascending, but I wanted to update everyone based on what I see looking at the trends over the last few days. There's little resistance between today's close and 2.80; if it breaks 2.80, the next level of resistance is around 3.01. If it breaks through...
For Monday, target entry between 2.28-2.34. I got in on Friday at 2.32 and use that number for return% below. Green trend line has held up multiple times with strong support, so you can set a tight stop-loss as high as 2.20. Conservative exit around 2.60 = ~12% return; high-score exit around 2.92 = ~26% return. Risk 5.17% @ 2.20 S/L. Reward:risk = 2.33...
Breakouts in past few weeks from the 1.76 - 2.24 price range indicate that the previous 2.24 resistance level could become a new support level.
Moving averages and analysts’ estimates make this company a good choice for short, medium and long-term investment, which in turn forecasts a larger volume spike coming soonhttps://www.tradingview.com/x/OfbMbWQl/.
My...
It can not be as straight as a line If I watch the pullback of this trend line breakout and the correction was to deep and have doubts because the price is now below the trend line but later now that the price again is above the trend line immediately my bias become bullish and I have more evidence to support my sentiment: I have a high volume bar, accompanied...
INFI seems forming a flag formation. Volume has increased significantly. It has good insider buying as well.
We think, If it can break its 50 day MA it will continue upward.
* Trade Criteria *
Date First Found- December 26, 2017
Pattern/Why- Fallen angel formation
Entry Target Criteria- Break $2.14 or $2.20
Exit Target Criteria- 1st Target $2.76, 2nd...
Infinity Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. The Company develops small molecule drugs that target disease pathways for potential applications in oncology. Its product candidate is duvelisib, also known as IPI-145, is an oral, dual-inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K), for the treatment of hematologic malignancies, or blood cancers. The Company is also developing IPI-549, which is an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the gamma isoform of PI3K. In addition to duvelisib, the Company focuses to generate new product candidates for potential investigation in oncology. The Company also focuses on developing DYNAMO, CONTEMPO, BRAVURA, FRESCO, DYNAMO+R, DUO, SYNCHRONY and Duvelisib + Venetoclax.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
INFI
